相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer
Panagiotis A. Konstantinopoulos et al.
GYNECOLOGIC ONCOLOGY (2014)
SAHA Regulates Histone Acetylation, Butyrylation, and Protein Expression in Neuroblastoma
Guofeng Xu et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Suberoylanilide Hydroxamic Acid (SAHA)-Induced Dynamics of a Human Histone Deacetylase Protein Interaction Network
Mihaela E. Sardiu et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Signatures of Natural Selection on Mutations of Residues with Multiple Posttranslational Modifications
Vanessa E. Gray et al.
MOLECULAR BIOLOGY AND EVOLUTION (2014)
Systematic analysis of the in situ crosstalk of tyrosine modifications reveals no additional natural selection on multiply modified residues
Zhicheng Pan et al.
SCIENTIFIC REPORTS (2014)
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer
A. Dasari et al.
INVESTIGATIONAL NEW DRUGS (2013)
Increasing Tip60 HAT Levels Rescues Axonal Transport Defects and Associated Behavioral Phenotypes in a Drosophila Alzheimer's Disease Model
Ashley A. Johnson et al.
JOURNAL OF NEUROSCIENCE (2013)
SAHA Treatment Reveals the Link between Histone Lysine Acetylation and Proteome in Nonsmall Cell Lung Cancer A549 Cells
Quan Wu et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Refined Preparation and Use of Anti-diglycine Remnant (K-ε-GG) Antibody Enables Routine Quantification of 10,000s of Ubiquitination Sites in Single Proteomics Experiments
Namrata D. Udeshi et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Expression of Leukemia-Associated Fusion Proteins Increases Sensitivity to Histone Deacetylase Inhibitor-Induced DNA Damage and Apoptosis
Luca A. Petruccelli et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer In Vitro and In Vivo
Hui-Wen Chiu et al.
PLOS ONE (2013)
Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells
Jae-Young Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Phase I Trial of Induction Histone Deacetylase and Proteasome Inhibition Followed by Surgery in Non-Small-Cell Lung Cancer
David R. Jones et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Global Identification and Characterization of Both O-GlcNAcylation and Phosphorylation at the Murine Synapse
Jonathan C. Trinidad et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Decitabine and Suberoylanilide Hydroxamic Acid (SAHA) Inhibit Growth of Ovarian Cancer Cell Lines and Xenografts While Inducing Expression of Imprinted Tumor Suppressor Genes, Apoptosis, G2/M Arrest, and Autophagy
Min-Yu Chen et al.
CANCER (2011)
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2011)
Quantitative Proteomics Analysis Reveals Molecular Networks Regulated by Epidermal Growth Factor Receptor Level in Head and Neck Cancer
Wei Yang et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and Exosomes
Jung Eun Park et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus subgroup B using SILAC coupled to LC-MS/MS
Diane C. Munday et al.
PROTEOMICS (2010)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
Multiple roles of HDAC inhibition in neurodegenerative conditions
De-Maw Chuang et al.
TRENDS IN NEUROSCIENCES (2009)
The age of crosstalk: Phosphorylation, ubiquitination, and beyond
Tony Hunter
MOLECULAR CELL (2007)
Histone deacetylase inhibitors: Overview and perspectives
Milos Dokmanovic et al.
MOLECULAR CANCER RESEARCH (2007)
Histone deacetylase inhibitors: molecular mechanisms of action
W. S. Xu et al.
ONCOGENE (2007)
Phase IIB multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
Elise A. Olsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Ubiquitination regulates PTEN nuclear import and tumor suppression
Lloyd C. Trotman et al.
CELL (2007)
Histone deacetylase inhibitors suppress the inducibility of nuclear factor-κB by tumor necrosis factor-α receptor-1 down-regulation
Gabriele Imre et al.
CANCER RESEARCH (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Ubiquitylation and cell signaling
K Haglund et al.
EMBO JOURNAL (2005)
Activity of suberoylanilide hydroxamic acid against human breast cancer cells with amplification of Her-2
P Bali et al.
CLINICAL CANCER RESEARCH (2005)
Regulatory cross-talk between lysine acetylation and ubiquitination: role in the control of protein stability
C Caron et al.
BIOESSAYS (2005)
The novel functions of ubiquitination in signaling
LJ Sun et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
RW Johnstone
NATURE REVIEWS DRUG DISCOVERY (2002)
Regulatory functions of ubiquitination in the immune system
Y Ben-Neriah
NATURE IMMUNOLOGY (2002)
Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasome
KD Wilkinson
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2000)
分享论文
